TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,805
|
18,790
|
16,813 |
Financial expenses |
40
|
52
|
6 |
Earnings before taxes |
1,014
|
1,795
|
1,216 |
Total assets |
8,871
|
9,241
|
7,467 |
Current assets |
8,867
|
9,205
|
7,410 |
Current liabilities |
1,984
|
2,727
|
2,066 |
Equity capital |
6,887
|
6,514
|
5,401 |
- share capital |
1,112
|
1,187
|
1,253 |
Employees (average) |
12
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.6%
|
70.5%
|
72.3% |
Turnover per employee |
1,566
|
1,868 | |
Profit as a percentage of turnover |
6.0%
|
9.6%
|
7.2% |
Return on assets (ROA) |
11.9%
|
20.0%
|
16.4% |
Current ratio |
446.9%
|
337.6%
|
358.7% |
Return on equity (ROE) |
14.7%
|
27.6%
|
22.5% |
Change turnover |
-792
|
2,860
|
2,498 |
Change turnover % |
-4%
|
18%
|
17% |
Chg. No. of employees |
3
|
-1 | |
Chg. No. of employees % |
33%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.